| Business

Become a contributor

Bookmark Econotimes

| Business

HSBC Cuts 10% of U.S. Debt Capital Markets Team Amid Ongoing Business Revamp

Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South

OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report

Hedge Funds Cut Nvidia, Amazon and Microsoft Stakes as AI Valuation Concerns Rise

Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings

Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand

AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months

European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA

Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift

Consumer Spending Shifts: Entertainment, Mobile Gaming and Digital Leisure Trends

NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16%

YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails

Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute

Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny

Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies

Nvidia Nears $30 Billion Investment in OpenAI, Replacing Previous $100 Billion AI Partnership

Microsoft Responds to ICE Surveillance Concerns Amid Azure Cloud Expansion

©Econometrics LLC . All Rights Reserved.

Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results

Monday, May 7, 2018 9:50 PM UTC

BUENA, N.J., May 07, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1^st quarter 2018 financial results and business update. This call will be rescheduled for 8:30am ET on Tuesday, May 8, 2018.

The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.

This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com.

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.

Contact:

Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Asian Currencies Slide as Strong US Dollar and Hawkish Fed Pressure Regional FX Markets

FxWirePro- Token Unlock Details

UAE's Strategic Bitcoin Empire: Mined, Not Bought

Tom Lee's BitMine Scoops Up $91M ETH at Rock-Bottom Prices – Now Holds 3.62% of Supply

Bitcoin Stuck in Bearish Rut: Sell Rallies Near $70K – Eyes $64K Support Next

Strait of Hormuz Shock Sends Crypto Fear Index to 10 – Extreme Panic or Epic Buy Dip?

Ethereum Cracks $2,000 Again – Bears Dominate: Sell Rallies to $2,068–70, Target $1,750/$1,500

Texas Attorney General Ken Paxton Sues Sanofi Over Alleged Healthcare Bribery Scheme

Indonesia–U.S. Reciprocal Trade Agreement Signals New Era of Economic Partnership

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results

Editor's Picks

Welcome to EconoTimes